A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
MPN Research Foundation
AstraZeneca
Yale University
The University of Texas Health Science Center at San Antonio
Assistance Publique - Hôpitaux de Paris
Institute of Hematology & Blood Diseases Hospital, China
Sun Yat-sen University
Second Xiangya Hospital of Central South University
AtlasMedx, Incorporated
IRCCS San Raffaele
Stanford University
Second Xiangya Hospital of Central South University
AC Camargo Cancer Center
Universitaire Ziekenhuizen KU Leuven
IRCCS San Raffaele
Kaohsiung Medical University Chung-Ho Memorial Hospital
Shanghai Zhongshan Hospital